🌐 WorldLive
Accueil🇺🇸 États-UnisActualités

OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document

OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document

2025 Audited financial statements are consistent with Unaudited financial statements previously reported on April 30, 2026 The IRIS Financing announced on May 28, 2026, was added as a subsequent event...